Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001595971-16-000001
Filing Date
2016-02-02
Accepted
2016-02-02 15:55:16
Documents
1
Effectiveness Date
2016-02-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8318
  Complete submission text file 0001595971-16-000001.txt   9376
Mailing Address 5956 SHERRY LANE SUITE 1810 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1810 DALLAS TX 75225 (214)706-4340
Agilis Biotherapeutics, LLC (Filer) CIK: 0001595971 (see all company filings)

EIN.: 463936833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-256536 | Film No.: 161380792